The offering in summary
Alligator Bioscience announced on February 8, 2024 its decision to perform a preferential rights issue, subject to the subsequent approval of the Extra General Meeting.
Preliminary timeline
- March 14, 2024 – Extraordinary General Meeting for, inter alia, approval of rights issue
- March 15, 2024 – Estimated publication of prospectus
- March 15, 2024 – Last day of trading incl. preferential rights
- March 18, 2024 – First day of trading excl. preferential rights
- March 19, 2024 – Record date
- March 21, 2024 – April 2, 2024 – Trading in unit rights
- March 21, 2024 – April 5, 2024 – Subscription period
- March 21, 2024 – April 25, 2024 – Trading in paid subscribed units (Sw. “BTU”)
- April 9, 2024 – Estimated publication of outcome in the Rights Issue
Read further!
- 21 March 2024 – Biostock – Alligator’s CEO on current development and the rights issue
- 27 March 2024 – Biostock – Alligator to maximise immuno oncology innovation
- 2 April 2024 – Biostock – Alligator Bioscience on the importance of prolonging life
Rights issue presentation at Biostock
Interested in joining?
The application form, without unit rights, can be found above under “Financial reports and other documentation“.
For nominee-registrated shareholders, please contact your nominee (e.g. Avanza, Nordnet, Handelsbanken, Swedbank etc.) where you have your shareholding in Alligator.
- Read more over at Avanza (login required)
- Read more over at Nordnet (login required)
If you are possibly not aware of your nominee, or are a directly registered shareholder, please reach out to the Issuing Agent, Vator Securities, by email: emissioner@vatorsec.se or phone: +46 (0) 8 5800 6591, and state in your email or call that it applies to Alligator.